Section Arrow
IMNN.NASDAQ
- Imunon Inc
Quotes are at least 15-min delayed:2026/04/19 05:49 EDT
Regular Hours
Last
 3.1
0 (0.00%)
Day High 
3.2 
Prev. Close
3.1 
1-M High
3.24 
Volume 
54.40K 
Bid
3.03
Ask
3.2
Day Low
3.04 
Open
3.16 
1-M Low
2.52 
Market Cap 
12.16M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 3.09 
20-SMA 2.98 
50-SMA 3.11 
52-W High 41.217391 
52-W Low 2.52 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-6.83/-1.93
Enterprise Value
12.76M
Balance Sheet
Book Value Per Share
1.80
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.06
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TOVXTheriva Biologics Inc0.2572+0.0049+1.94%0.09PE
PBMPsyence Biomedical Ltd.7.6+1.73+29.47%-- 
GERNGeron Corp1.68-0.01-0.59%-- 
IBRXImmunityBio7.7+0.45+6.21%-- 
ADMAADMA Biologics11.01+0.27+2.51%17.92PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovariancancer.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.